Nucleic acid linked to a trivalent glycoconjugate
AssigneeSilence Therapeutics GmbH
InventorsChristian Frauendorf, Mark Cameron
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound comprising a modified saccharide moiety conjugated to a nucleic acid. The compound is useful in medicine for RNA interference therapy or for research and diagnostic purposes. In particular, the compound is useful in treating liver disease.
Claims36
A compound having the formula (I):
- [S—X1—P—X2]3-A-X3—Z (I)
- wherein:
- S represents a saccharide;
- X1 represents C3-C6 alkylene or an ethylene glycol stem (—CH2—CH2—O)m(—CH2)2— wherein m is 1, 2, or 3;
- P is a modified phosphate;
- X2 is alkylene or an alkylene ether of the formula (—CH2)n—O—CH2— where n=1-6;
- A is a branching unit;
- X3 represents a bridging unit;
- Z is a nucleic acid;
- and where the linkage between X3 and Z is a phosphate or thiophosphate.
A compound according to any preceding claim, wherein the modified phosphate is a thiophosphate.
A compound according to any preceding claim, wherein the saccharide is selected from N-acetyl galactosamine, mannose, galactose, glucose, glucosamine and fructose.
A compound according to any preceding claim, wherein X1 is an ethylene glycol stem (—CH2—CH2—O)m(—CH2)2— wherein m is 1, 2, or 3.
A compound according to any preceding claim, wherein X1 represents C3-C6 alkylene.
A compound of formula:
- wherein Z is a nucleic acid.
A compound of formula:
- wherein Z is a nucleic acid.
A compound of formula:
- wherein Z is a nucleic acid.
A compound of formula:
- wherein Z is a nucleic acid.
A compound of formula:
- wherein Z is a nucleic acid.
A compound of formula:
- wherein Z is a nucleic acid.
A compound of formula:
- wherein Z is a nucleic acid.
A compound of formula:
- wherein Z is a nucleic acid.
A compound according to any preceding claim, wherein the nucleic acid is selected from RNAi, siRNA, antisense nucleic acid, ribozymes, aptamers and spiegelmers.
A compound according to any preceding claim, wherein the nucleic acid is modified.
Dependencies are inferred from the claim text.